Tekla Healthcare Investors

NYSE:HQH

18.29 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 2.6532.65375.2392.33225.2052.81456.0592.15818.5871.97858.6631.60830.3651.63247.7711.95644.252.51195.9251.9451.8551.8551.8951.8951.4971.4971.3991.3991.411.411.2351.2351.1661.1661.3621.3620.8040.8040.5850.5850.4880.4880.5140.5140.4640.464
Cost of Revenue 005.40105.49405.39905.89706.26605.90405.43204.99104.949000000000000000000000000000
Gross Profit 2.6532.65369.8382.33219.7112.81450.662.15812.691.97852.3971.60824.4611.63242.341.95639.2592.51190.9761.9451.8551.8551.8951.8951.4971.4971.3991.3991.411.411.2351.2351.1661.1661.3621.3620.8040.8040.5850.5850.4880.4880.5140.5140.4640.464
Gross Profit Ratio 110.92810.78210.90410.68310.89310.80610.88610.88710.948111111111111111111111111111
Reseach & Development Expenses 0000000000000000000000000000000000000000000000
General & Administrative Expenses 2.6592.6592.8432.8432.8952.8952.8742.8743.0973.0973.2763.2763.083.082.8432.8432.612.612.5752.5752.6612.6612.7292.7292.7242.7242.82.82.5922.5922.6442.6442.8982.8983.2173.2172.8752.8752.4632.4632.1882.1881.9111.9111.7051.705
Selling & Marketing Expenses 0.0090.00900000000000000000000000000000000000000000000
SG&A 2.6682.6682.8432.8432.8952.8952.8742.8743.0973.0973.2763.2763.083.082.8432.8432.612.612.5752.5752.6612.6612.7292.7292.7242.7242.82.82.5922.5922.6442.6442.8982.8983.2173.2172.8752.8752.4632.4632.1882.1881.9111.9111.7051.705
Other Expenses 00-0000-000000000000-0000000000000000000000000000
Operating Expenses 2.66847.19615.74615.74638.76838.76841.74841.74859.50259.50231.69631.69642.65242.65294.63194.63121.50521.50532.39632.39644.05244.05265.46265.46234.25234.25241.3941.3916.44216.44230.00630.00660.41660.41655.84555.845101.762101.76263.79363.79346.14346.14366.33266.33232.73132.731
Operating Income 99.697-0.016-26.821-0.51183.16-0.082-79.181-0.716-115.054-1.11966.607-1.66888.587-1.447193.202-0.88748.028-0.099-60.901-0.63-0.806-0.806-0.834-0.834-1.226-1.226-1.4-1.4-1.182-1.182-1.409-1.409-1.732-1.732-1.855-1.855-2.071-2.071-1.878-1.878-1.7-1.7-1.397-1.397-1.241-1.241
Operating Income Ratio 37.584-0.006-0.356-0.2193.299-0.029-1.412-0.332-6.19-0.5661.135-1.0372.917-0.8874.044-0.4531.085-0.04-0.635-0.324-0.435-0.435-0.44-0.44-0.819-0.819-1.001-1.001-0.838-0.838-1.141-1.141-1.486-1.486-1.362-1.362-2.576-2.576-3.214-3.214-3.487-3.487-2.716-2.716-2.676-2.676
Total Other Income Expenses Net -49.84949.864-0.007-12.9030.00341.663-0-38.8740.005-56.406034.971-0.01845.732-0.02897.4730.00324.115-60.271-29.821-83.588-41.391135.54768.191-64.283-31.52886.97844.18936.88719.03432.6532.65-57.518-57.518-52.629-52.629104.637104.63766.25666.25648.33148.33168.24368.24334.43634.436
Income Before Tax 49.84949.849-26.828-13.41483.16341.582-79.181-39.59-115.048-57.52466.60733.30388.56944.284193.17496.58748.03124.015-0-30.45-42.197-42.19767.35667.356-32.755-32.75542.78942.78917.85217.85231.24131.241-59.251-59.251-54.483-54.483102.566102.56664.37864.37846.63146.63166.84666.84633.19433.194
Income Before Tax Ratio 18.79218.792-0.357-5.7523.29914.777-1.412-18.35-6.19-29.0841.13520.7142.91727.1294.04449.381.0859.566-0-15.653-22.746-22.74635.55235.552-21.876-21.87630.58130.58112.65812.65825.29225.292-50.837-50.837-40.001-40.001127.609127.609110.137110.13795.65195.651129.966129.96671.55671.556
Income Tax Expense 049.864-0-12.903041.663-0-38.874-1.119-56.40633.30334.971-1.44745.732-0.88797.473-0.09924.115-0-29.821-41.391-41.39168.19168.191-31.528-31.52844.18944.18919.03419.03432.6532.65-57.518-57.518-52.629-52.629104.637104.63766.25666.25648.33148.33168.24368.24334.43634.436
Net Income 49.84949.849-26.828-13.41483.16341.582-79.181-39.59-115.048-57.52466.60733.30388.56944.284193.17496.58748.03124.01542.826-30.45-42.197-42.19767.35667.356-32.755-32.75542.78942.78917.85217.85231.24131.241-59.251-59.251-54.483-54.483102.566102.56664.37864.37846.63146.63166.84666.84633.19433.194
Net Income Ratio 18.79218.792-0.357-5.7523.29914.777-1.412-18.35-6.19-29.0841.13520.7142.91727.1294.04449.381.0859.5660.446-15.653-22.746-22.74635.55235.552-21.876-21.87630.58130.58112.65812.65825.29225.292-50.837-50.837-40.001-40.001127.609127.609110.137110.13795.65195.651129.966129.96671.55671.556
EPS 0.980.98-0.54-0.271.720.86-1.67-0.84-2.48-1.241.470.731.990.994.422.21.110.561-0.71-1-11.61.6-0.79-0.791.051.050.450.450.80.8-1.55-1.55-1.46-1.462.812.811.81.81.651.652.412.411.221.22
EPS Diluted 0.980.98-0.54-0.271.720.86-1.67-0.84-2.48-1.241.470.731.990.994.422.21.110.561-0.71-1-11.61.6-0.79-0.791.051.050.450.450.80.8-1.55-1.55-1.46-1.462.812.811.81.81.651.652.412.411.221.22
EBITDA 99.71349.864-26.821083.160-78.464-38.874-113.935-56.40668.27534.97190.03445.732193.202048.12724.115-60.901-29.8210-41.391135.54768.1910-31.52886.97844.18936.88719.03400-57.518-57.518-52.629-52.629104.637104.63700000034.43634.436
EBITDA Ratio 37.5918.798-0.356-5.5333.29914.806-1.412-18.018-6.19-28.5181.13521.7512.91728.0164.04449.8341.0859.605-0.311-15.329-22.312-22.31235.99235.992-21.057-21.05731.58231.58213.49613.49626.43326.433-49.351-49.351-38.64-38.64130.186130.186113.351113.35199.13899.138132.681132.68174.23274.232